Three Advanced Clinical Decision Tools.
One Powerful System.
Comprehensive physiologic and anatomic insights guide a
personalized treatment plan for every patient.
- The FFRangio I IMPACT** adds important context around the burden of CAD across the full tree.
- The FFRangio I PULLBACK shows where FFR drops occur, helping you differentiate diffuse from focal disease and target the most important areas.
3. NEW FFRANGIO | SIZE
New vessel sizing tool based on accurate 3D QCA allows you to quickly estimate lesion lengths and vessel diameters for procedural planning. The sizing tool is displayed on the 3D QCA chart and angiograms for anatomical context.
Treat Confidently with FFRangio†
The FFRangio System consistently demonstrates excellent diagnostic performance compared to traditional FFR wires, with strong results across a wide spectrum of patients and lesion subgroups.View Clinical Studies
Quick, real-time intraprocedural results to optimize and confirm* PCI decisions
Eliminate risk, complexity, and limitations of invasive FFR wires and hyperemic agents
Compatible with all major C-arm angiography systems
Improve outcomes while reducing costs‡
* Diagnostic performance of FFRangio compared to FFR wires has not been established for lesions immediately after PCI.
** Patent pending
† Witberg, et al. Diagnostic performance of angiogram-derived fractional flow reserve. J Am Coll Cariol Intv 2020. DOI: 10.1016/j.jcin.2019.10.045
‡FAME trial: FFR-guided PCI improves outcomes and reduces cost compared to angiography-guided PCI. Tonino, et al. N Engl J Med. January 15, 2009; 360:213-224; Fearon et al. Circulation. 2010;122:2545-2550;